Literature DB >> 23817035

Central venous catheter infections in outpatients with pulmonary hypertension treated with continuous iloprost.

Stephan Keusch1, Rudolf Speich, Ulla Treder, Silvia Ulrich Somaini.   

Abstract

BACKGROUND: Intravenous prostanoid therapy is one cornerstone of therapy for patients with pre-capillary pulmonary hypertension (PH). Long-term central venous catheters expose patients to infectious complications.
OBJECTIVES: We report the incidence of catheter-related infection (CRI) and the spectrum of bacteria for ambulatory PH patients treated with iloprost via non-tunnelled central venous catheters from our Swiss referral centre in Zurich.
METHODS: Data from 15 PH patients treated with intravenous iloprost between May 2000 and June 2012 were reviewed.
RESULTS: We found 11 CRI in 4 cases by two different organisms. Pathogens found were Brevibacterium (55%), Micrococcus luteus (18%), coagulase-negative Staphylococcus (9%) and Staphylococcus aureus (9%), as well as unusual organisms such as Agrobacterium tumefaciens or Delftia tsuruhatensis. The overall CRI rate was 1.28 per 1,000 catheter days, or 0.47 per year.
CONCLUSIONS: The incidence of CRI using long-term, non-tunnelled central venous catheters in PH patients treated with iloprost is low. Uncommon, rare pathogens causing CRI were found in a substantial number of patients.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817035     DOI: 10.1159/000350441

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

1.  Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension.

Authors:  Manuel J Richter; Ralf Ewert; Christian Warnke; Henning Gall; Simon Classen; Friedrich Grimminger; Eckhard Mayer; Werner Seeger; Hossein-Ardeschir Ghofrani
Journal:  Clin Res Cardiol       Date:  2016-09-26       Impact factor: 5.460

2.  Molecular identification of clinical "difficult-to-identify" microbes from sequencing 16S ribosomal DNA and internal transcribed spacer 2.

Authors:  Cancan Cheng; Jingjing Sun; Fen Zheng; Kuihai Wu; Yongyu Rui
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-01-03       Impact factor: 3.944

3.  Draft Genome Sequence of Delftia tsuruhatensis MTQ3, a Strain of Plant Growth-Promoting Rhizobacterium with Antimicrobial Activity.

Authors:  Qihui Hou; Chengqiang Wang; Haimeng Guo; Zhilin Xia; Jiangping Ye; Kai Liu; Yanan Yang; Xiaoyang Hou; Hu Liu; Jun Wang; Binghai Du; Yanqin Ding
Journal:  Genome Announc       Date:  2015-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.